ArticleMolecular carcinogenesis2022

Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP-TUG1/miR-4726-5p/MUC1 pathway.

Qing Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.